Real-time context
Upgrades, downgrades, initiations, and price-target changes.
Rating Change Citigroup analysts reiterated a Buy rating on Riot Platforms, Inc. (NASDAQ:RIOT) on July 08, 2026. Market Context Riot Platforms, Inc.
Read moreRating Change Morgan Stanley analysts downgraded Lemonade, Inc. (NYSE:LMND) from Overweight to Equal-Weight on July 08, 2026. Market Context Lemonade, Inc.
Read moreRating Change Keefe, Bruyette & Woods analysts reiterated a Underperform rating on Lemonade, Inc. (NYSE:LMND) on July 08, 2026. Market Context Lemonade, Inc.
Read moreRating Change Susquehanna analysts reiterated a Positive rating on NOV Inc. (NYSE:NOV) on July 08, 2026. Market Context NOV Inc.
Read moreRating Change UBS analysts reiterated a Neutral rating on Healthcare Realty Trust Incorporated (NYSE:HR) on July 08, 2026. Market Context Healthcare Realty Trust Incorporated…
Read moreRating Change Keefe, Bruyette & Woods analysts reiterated a Market Perform rating on American Financial Group, Inc. (NYSE:AFG) on July 08, 2026. Market Context American Financial…
Read moreRating Change UBS analysts reiterated a Neutral rating on American Homes 4 Rent (NYSE:AMH) on July 08, 2026. Market Context American Homes 4 Rent operates in the Real Estate…
Read moreRating Change Ladenburg Thalmann analysts reiterated a Buy rating on BXP, Inc. (NYSE:BXP) on July 08, 2026. Market Context BXP, Inc.
Read moreRating Change JP Morgan analysts reiterated a Neutral rating on Antero Resources Corporation (NYSE:AR) on July 08, 2026. Market Context Antero Resources Corporation operates in…
Read moreRating Change Keefe, Bruyette & Woods analysts reiterated a Outperform rating on Assurant, Inc. (NYSE:AIZ) on July 08, 2026. Market Context Assurant, Inc.
Read moreRating Change HC Wainwright & Co. analysts reiterated a Buy rating on Enliven Therapeutics, Inc. (NASDAQ:ELVN) on July 09, 2026.
Read moreRating Change Mizuho analysts upgraded Five Below, Inc. (NASDAQ:FIVE) from Neutral to Outperform on July 09, 2026. Market Context Five Below, Inc.
Read moreRating Change Morgan Stanley analysts reiterated a Equal-Weight rating on Moderna, Inc. (NASDAQ:MRNA) on July 08, 2026. Market Context Moderna, Inc.
Read moreRating Change UBS analysts reiterated a Neutral rating on Healthpeak Properties, Inc. (NYSE:DOC) on July 08, 2026. Market Context Healthpeak Properties, Inc.
Read moreRating Change Truist Securities analysts downgraded UDR, Inc. (NYSE:UDR) from Buy to Hold on July 08, 2026. Market Context UDR, Inc.
Read moreRating Change Stifel analysts reiterated a Hold rating on Globus Medical, Inc. (NYSE:GMED) on July 08, 2026. Market Context Globus Medical, Inc.
Read moreRating Change BWS Financial analysts reiterated a Buy rating on Ubiquiti Inc. (NYSE:UI) on July 08, 2026. Market Context Ubiquiti Inc.
Read moreRating Change Wells Fargo analysts reiterated a Overweight rating on Amrize Ltd (NYSE:AMRZ) on July 08, 2026. Market Context Amrize Ltd operates in the Basic Materials sector. The…
Read moreRating Change Keefe, Bruyette & Woods analysts reiterated a Market Perform rating on Arch Capital Group Ltd. (NASDAQ:ACGL) on July 08, 2026. Market Context Arch Capital Group Ltd.
Read moreRating Change UBS analysts reiterated a Buy rating on Arch Capital Group Ltd. (NASDAQ:ACGL) on July 08, 2026. Market Context Arch Capital Group Ltd.
Read more
